Skip to content
Search

Latest Stories

Three quarters of people visited a pharmacist for minor ailments during the pandemic: Study

Over three quarters (77pc) of respondents of a national poll agreed that it was more appropriate and more convenient for them to visit a pharmacist for minor ailments during the pandemic.

However, the new research also highlights a growing need for pharmacy to tackle a ticking time bomb of negative health behaviours that are beginning to emerge.


As selfcare takes centre stage, the survey, conducted jointly by market research company 3Gem Research & Insights and health communications agency Pegasus, discovered that the under 60s were leading the way in the movement.

20 per cent of under 60s purchased more multivitamins and 17 per cent bought more immunity boosting vitamins during the pandemic. In addition, more than a third (34pc) of under 30s were doing more home work-outs and 31 per cent were snacking on fruit and vegetables more often.

The findings also highlight a decreased reliance on the GP for minor ailments. However, the data does also suggest a few areas could be falling through the gaps with a reduction in GP visits for areas such as anxiety and stress but seemingly no uplift in pharmacy visits.

Trust in pharmacist is highest

Trust in the pharmacist is highest in the 50 and over age group where 71 per cent would trust a pharmacist to provide advice on diagnosing minor ailments, 83 per cent to provide advice on medicines and 66 per cent for advice on flu vaccines.

Pharmacy continues to represent a key retail channel with 39 per cent of people buying non-prescription medicines in store at pharmacies, with more than half (52pc) of those buying in this channel (n=1571) stating this is due to convenience and 32pc stating this is due to the advice pharmacists are able to provide about the products they’re buying.

Whilst general attitudes to pharmacy and self-care for minor ailments are promising, the pandemics overall negative impact on wellbeing is concerning.

Significant numbers have gained weight (43p), and one in ten (10pc) are smoking more often.

Mental health is also a concern with more people experiencing conditions such as stress and anxiety, along with trouble sleeping.

Fewer people are seeking healthcare professional advice for these, than before the pandemic, creating a need for pharmacy to seize their trusted position and ensure their mental health offerings, alongside smoking cessation and weight-loss services are front and centre.

Helen Donovan, Self Care Forum chair and professional lead for Public Health at the Royal College of Nursing, said: “The results around increased trust in the pharmacist is hugely encouraging, but this data also throws up some real concerns around the negative impact the pandemic has had on our health.  However, these are areas where the community pharmacist can make a real impact and provide support in areas that are currently being missed completely.”

Sallyanne Smith, director at Pegasus adds: “Health communications is an area where data has always played a key role, but now more than ever we need to ensure we’re fully aware of both the positive and negative impact the pandemic has had on health and how it has influenced the choices people are making.

"As we hope to see a return to normality in 2021 it’s likely many people will look to regain control on their health and wellbeing. Pharmacies, and the OTC brands stocked within them, are not only well placed to support people with this but are finally gaining the recognition they deserve.”

The online survey of 4,000 UK nationally representative UK adults was carried out in the week between Oct 22 and October 29, 2020.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less